Bacterial keratitis: Perspective on epidemiology, Clinico-Pathogenesis, diagnosis and treatment

Sultan Qaboos University Medical Journal

Volumn 9, Issue 2, 2009, Pages 184-195

  Al Mujaini, Abdullah ^a   Al Kharusi, Nadia ^a   Thakral, Archana ^a   Wali, Upender K ^a  

^a SULTAN QABOOS UNIVERSITY HOSPITAL   (Oman)

Author keywords

Contact lens; Keratitis; Toxins

Indexed keywords

EID: 84890559860     PISSN: 2075051X     EISSN: 20750528     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Bialasiewicz AA, Schonherr U, Schmitt T, Naumann GOH. Triple therapeutic approach for keratitis. In: Bialasiewicz AA, Schaal KP, Eds. Infectious diseases of the eye. Buren: Aeolus Press, 1985. p. 266.
2. Schaefer F, Bruttin O, Zagrafos L, Guex-Corsier Y. Bacterial keratitis: a prospective clinical and microbiological Study. Br J Ophthalmol 2001; 85:842-7.
3. Bernet HA, Hay J, Kirkness CM. Antimicrobial management of presumed microbial keratitis: Guidelines for treatment for central and peripheral ulcers. Br J Ophthalmol 1998; 82:137-45.
4. Vajpayee RB, Dada T, Saxena R, Vajpayee M, Taylor HR, Venkatesh P, et al. Study of the first Contact management profile of cases of infective keratitis: a hospital based study. Cornea 2000; 19:52-6.
5. Erie JC, Nevitt MP, Hodge DO, Ballard DJ. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol 1993; 111:1665-71.
6. Upadhyay MP, Karamcharya PC, Koirala S, Shah DN, Shakya S, Shrestha JK, et al. The Bhaktapur eye study: Ocular trauma and antibiotic prophylaxis for the prevention of corneal ulcers in Nepal. Br J Ophthalmol 2001; 85:388-92.
7. Ormerod LD, Hertzmark E, Gomez DS, Stabiner RG, Schanzlin DJ, Smith RE. Epidemiology of Microbial keratitis in Southern California. Ophthalmology 1987; 94:1322-33.
8. Neumann M, Sjostrand J. Central microbial keratitis in a Swedish city population. Acta Ophthalmol Copenh 1993; 71:160-4.
9. Poggio EC, Glynn RJ, Schein OD, Seddon JM, Shannon MJ, Scardino VA, et al. The incidence of ulcerative keratitis among users of daily wears and extended wear soft contact lenses. N Engl J Med 1989; 321:779-83.
10. Bialasiewicz A, Shenoy R, Thakral A, Al-Muniri A, Shenoy U, Al-Mughairi Z. Microbial keratitis: a 4 year study of risk factors and traditional/ complementary medicine in Oman. Ophthalmologe 2006; 103:682-7.
11. Al-Hazzaa SAF, Tabbara KF. Bacterial keratitis after penetrating keratoplasty. Ophthalmology 1988; 95:1504.
12. Tuberville AW, Wood TO. Corneal ulcers in corneal transplantation. Curr Eye Res 1981; 8:479.
13. Badenoch PR, Aggarwal RK, Coster DJ. Clostridium perfringens keratitis after penetrating keratoplasty. Aust NZ J Ophthalmol 1995; 23:245.
14. Synder RW, Hyndiuk RA. Mechanisms of bacterial invasion of the cornea. In: Tasman W, Jaeger EA, Eds. Duane‘s Foundations of Clinical Ophthalmology. Philadelphia: J B Lippincott & Co., 1990. pp. 11-44.
15. Reichart R, Stern GA. Qualitative adherence of bacteria to human corneal epithelial cells. Arch Ophthalmol 1984; 102:1394.
16. Panjwani N, Clerk B, Cohen M, Barza M, Baum J. Differential binding of Ps. aeruginosa and Staph. aureus to corneal epithelium in culture. Invest Ophthalmol Vis Sci 1990; 31:696.
17. Klotz SA, An YK, Misra RP. A partial thickness epithelial defect increases adherence of Ps. aeruginosa to the cornea. Invest Ophthalmol Vis Sci 1989; 30:1069.
18. John T, Refojo MF, Hanninen L, Leong FL, Medina A, Kenyon KR. Adherence of viable and non-viable bacteria to soft contact lenses. Cornea 1989; 8:21.
19. Stern GA, Lubiniewski A, Allen C. The interaction between Ps. aeruginosa and the corneal epithelium. Arch Ophthalmol 1985; 103:1221.
20. Speziale P, Raucci G, Visai L, Switalski LM, Timpl R. Binding of collagen to Staph. aureus. J Bacteriol 1986; 167:77-81.
21. Slusher MM, Myrvik QN, Lewis JC, Gristina AG. Extended wear lenses, biofilm and bacterial adhesion. Arch Ophthalmol 1987; 105:110.
22. Aswad MI, Barza M, Baun J. Effect of lid closure on contact lens associated Ps. keratitis. Arch Ophthalmol 1989; 107:1667.
23. Miller MJ, Wilson LA, Ahearn DG. Adherence of Ps. aeruginosa to rigid gas permeable contact lenses. Arch Ophthalmol 1991; 9:1447.
24. Mathews TD, Frazer DG, Minassian DC. Risks of keratitis and patterns of use with disposable contact lenses. Arch Ophthalmol 1992; 110:1559.
25. Ormerod LD, Smite RE. Contact lens associated microbial keratitis. Arch Ophthalmol 1986; 104:7.
26. O’Day DM, Ho PC, Andrews JS. Mechanisms of tissue destruction in ocular Bacillus cereus infections. In: Roper T, Ed. The cornea in health and disease. San Diego: Academic Press, 1981. p. 403.
27. Turner L, Stinson I. Mycobacterium fortuitum as a cause of corneal ulcer. Am J Ophthalmol 1965; 60:329.
28. Sridhar MS, Sharma S, Garg P, Rao GN. Treatment and outcome of nocardia keratitis. Cornea 2001; 20:458-62.
29. Hyundik RA. Experimental pseudomonas keratitis. Trans Am Ophthalmol Soc 1981; 79:541-624.
30. Ostler HB, Thygeson P, Okumoto M, Weddell J. Opportunistic ocular infections. Am Fam Physician 1978; 17:134-40.
31. Asbell P, Stenson S. Ulcerative keratitis survey of 30 years laboratory experience. Arch Ophthalmol 1982; 100:77.
32. Groden LR, Rodnite J, Brinser JH, Genvert GI. Acridine orange and Gram‘s stain in infectious keratitis. Cornea 1990; 9:122-4.
33. Wahl JC, Katz HR, Abrams DA. Infectious keratitis in Baltimore. Ann Ophthalmol 1991; 23:234.
34. Jones DB. Initial therapy of suspected microbial corneal ulcers II. Specific antibiotic therapy based on corneal scrapings. Surv Ophthalmol 1979; 24:97.
35. Jones DB. Polymicrobial keratitis. Trans Am Ophthalmol Soc 1981; 79:153.
36. Liesegang TJ, Forster RF. Spectrum of microbial keratitis in Southern Florida. Am J Ophthalmol 1980; 90:38.
37. Baum J, Barza M. The evolution of antibiotic therapy of bacterial conjunctivitis and keratitis: 1970-2000. Cornea 2000; 19:659-72.
38. Jones DB. A plan for antimicrobial therapy in bacterial keratitis. Trans Am Acad Ophthalmol Otolaryngol 1975; 79:95.
39. Reidy JJ, Hobden JA, Hill JM, Forman K, O’Callaghan RJ. The efficacy of topical ciprofloxacin and norfloxacin in the treatment of experimental Pseudomonas keratitis. Cornea 1992; 10:25.
40. Insler MS. Successful treatment of MRSA keratitis with topical ciprofloxacin. Ophthalmology 1991; 98:1690.
41. Kaatz GW, Seo SM. Mechanism of ciprofloxacin resistance in Pseudomonas aeruginosa. J Infect Dis 1988; 58:537.
42. Jhanji V, Sharma N, Satpathy G, Tityal J. Fourth generation fluoroquinolone-resistant bacterial keratitis. J Cataract & Refract Surg 2007; 33:1488-9.
43. Kaliamurthy J, Jesudasan CAN, Geraldine P, Parmar P. Comparison of in vitro susceptibilities of ocular bacterial isolates to gatifloxacin and other topical antibiotics. Ophthalmic Res 2005; 37:117-22.
44. Parmar P, Salman A, Kalavathy CM, Kaliamurthy J, Prasanth DA, Thomas PA et al. Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. Am J Ophthalmol 2006; 141:282-6.
45. Michael KJ, Richard GF. Selecting between gatifloxacin and moxifloxacin drops in ambulatory ophthalmic surgery. Am J Health Syst Pharm 2006; 63:637-40.
46. Callegan MC, Ramirez R, Kane ST, Cochran DC, Jensen H. Antibacterial activity of the fourth generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther 2003; 20:246-52.
47. Lehokar S, Sidhu N, Mirdha BR. Comparison of topical 0.3% ofloxacin to fortified tobramycincefazolin in the therapy of bacterial keratitis. Infection 2000; 28:149-52.
48. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in S. Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000; 107:1497-502.
49. Baum J. Bacterial keratitis. In: Schlossberg D, Ed. Current Therapy of Infectious Disease. Philadelphia: W.B. Saunders Company, 2002.
50. Stern GA, Buttross M. Use of corticosteroids in combination with antimicrobials in the treatment of infections and corneal diseases. Ophthalmology 1991; 98:847.
51. Davis SD, Sarff LD, Hynduik RA. Corticosteroids in experimentally induced Pseudomonas keratitis. Arch Ophthalmol 1987; 96:126.
52. Smolin G, Okumoto M, Leongsit L. Combined gentamicin, tobramicin, corticosteroid treatment II: effect on gentamicin resistant Ps keratitis. Arch Ophthalmol 1980; 98:473.
53. Harbin T. Recurrence of a corneal Pseudomonas infection after topical steroid therapy: case report. Am J Ophthalmol 1964; 58:670.
54. Coster DJ, Bodenoch PR. Host, microbial and pharmacological factors affecting the outcome of suppurative keratits. Br J Ophthalmol 1987; 71:96.
55. Ormerod LD, Hertzmark E, Gomez DS, Stabiner RG, Schanzlin DJ, Smith RE. Epidemiology of microbial keratitis in Southern California. Ophthalmology 1987; 94:1322-33.
56. Gudmundsson OG, Ormerod LD, Kenyon KR, Glynn RJ, Baker AS, Haaf J, et al. Factors influencing predilection and outcome of bacterial keratitis. Cornea 1989; 8:115.
57. Klauss V, Scaller UC, Bialasiewicz AA. Antiseptic prophylaxis and therapy in ocular infections. In: Kramer A, Behrens-Baumann W, Eds. Infectious Eye Diseases. 1st ed. Basel: S. Karger AG, 2002. pp. 145-90.
58. Shah R, Shah M, Khandekar R, Al-Raisi A. Contact lens induced corneal ulcer management in a tertiary eye unit in Oman-A descriptive study. SQU Med J 2008; 8:283-90.